Issue 47, 2007

Carboranyl thymidine analogues for neutron capture therapy

Abstract

Neutron capture therapy (NCT) is a binary radio-chemotherapeutic modality for the treatment of cancer. A major focus of NCT-related research is the development of novel tumor-selective agents that serve as the chemical component in NCT. Thymidine analogues substituted with a boron-containing carborane cluster at the N3 position, designated 3CTAs (3-carboranyl thymidine analogues), constitute one class of these new improved NCT agents. Their chemical, structural and biological properties are discussed in this Feature Article.

Graphical abstract: Carboranyl thymidine analogues for neutron capture therapy

Article information

Article type
Feature Article
Submitted
14 May 2007
Accepted
17 Jul 2007
First published
15 Aug 2007

Chem. Commun., 2007, 4978-4991

Carboranyl thymidine analogues for neutron capture therapy

W. Tjarks, R. Tiwari, Y. Byun, S. Narayanasamy and Rolf. F. Barth, Chem. Commun., 2007, 4978 DOI: 10.1039/B707257K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements